70290-38-9

Basic information

• Product Name: 2-Methylthio-5-nitrobenzoic acid
• Synonyms: 2-Methylthio-5-nitrobenzoic acid
• CAS NO: 70290-38-9
• Molecular Formula: C₈H₇NO₄S
• Molecular Weight: 213.21
• Mol File: 70290-38-9.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-Methylthio-5-nitrobenzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Methylthio-5-nitrobenzoic acid(70290-38-9)
• EPA Substance Registry System: 2-Methylthio-5-nitrobenzoic acid(70290-38-9)

Safety Data

• Hazardous Substances Data: 70290-38-9(Hazardous Substances Data)

Upstream product

• 7304-32-7 2-fluoro-5-nitrobenzoic acid 
• 5188-07-8 sodium thiomethoxide 
• 74-93-1 methylthiol 
• 6307-82-0 2-chloro-5-nitro-benzoic acid methyl ester 

Downstream Products

• 70290-39-0 2-Methylthio-5-aminobenzoesaeure 
• 191604-70-3 methyl 2-methylthio-5-nitrobenzoate 

Relevant articles and documents

A highly selective fluorogenic substrate for imaging glutathione S-transferase P1: Development and cellular applicability in epigenetic studies

Pi-class glutathione S-transferase (GSTP1) is a molecular marker enzyme whose expression level is altered in various malignant tumour tissues. Herein, we report the first highly selective fluorogenic GSTP1 substrate, Ps-TG, and its membrane-permeable deri

Novel substituted 4-(1H-benzimidazol-2-yl) [1,4]diazepanes useful for the treatment of allergic diseases

The present invention relates to novel 4-(1H-benzimidazol-2-yl)[1,4]diazepane derivatives of formula and stereoisomers thereof, and pharmaceutically acceptable salts thereof which are useful as histamine receptor antagonists and tachykinin receptor antagonist. Such antagonists are useful in the treatment of allergic rhinitis, including seasonal rhinitis and sinusitis; inflammatory bowel diseases, including Crohn's disease and ulcerative colitis; asthma; bronchitis; and emesis.

Substituted 4-(1H-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases

The present invention relates to novel substituted piperidine derivatives of formula (1), stereoisomers thereof, and pharmaceutically acceptable salts thereof which are useful as histamine receptor antagonists and tachykinin receptor antagonist. Such antagonists are useful in the treatment of allergic rhinitis, including seasonal rhinitis and sinusitis; inflammatory bowel diseases, including Crohn's disease and ulcerative colitis; asthma; bronchitis; and emesis.